Core Viewpoint - Zhejiang Dongri has experienced a significant stock price surge due to market speculation linking it to brain-computer interface technology, despite its primary business being in agricultural products and related services [1][2][8]. Company Overview - Zhejiang Dongri operates in the agricultural sector, focusing on wholesale market operations, food distribution, and tofu production [8]. - The company has adopted a "1+2+N" business model, where "1" refers to market operations, "2" includes food distribution and tofu production, and "N" encompasses various technology-driven initiatives [3]. Recent Developments - In 2024, Zhejiang Dongri established Peianmei Technology Co., Ltd. to collaborate with medical universities on special medical foods and nutrition therapy [6]. - A strategic cooperation intention was announced with Capital Medical University to advance brain-computer interface technology, which has led to speculation and a surge in stock price [6][7]. Stock Performance - From June 17 to June 27, Zhejiang Dongri's stock price increased by 99%, achieving six trading limit-ups in nine days [2][8]. - The company reported a cumulative price increase of 100% over ten trading days, prompting a notice of abnormal trading activity [8]. Financial Impact - Peianmei reported minimal financial impact on Zhejiang Dongri, with a revenue of 2.87 thousand yuan and a net loss of 66.14 thousand yuan for the current year [8]. - The company aims to achieve over 900 million yuan in main business revenue in 2025, with approximately 1.7 million yuan in revenue reported for the first quarter of 2024 [9].
9个交易日股价大涨99% “脑机接口”概念股浙江东日澄清:我们主业是管菜市场和卖豆腐!